177 related articles for article (PubMed ID: 34234468)
1. Isolation and Characterization of Chemo-Resistant Stem Cells from a Mouse Model of Hereditary Non-Polyposis Colon Cancer.
Telang N
Stem Cells Cloning; 2021; 14():19-25. PubMed ID: 34234468
[TBL] [Abstract][Full Text] [Related]
2. Stem cell models for genetically predisposed colon cancer.
Telang N
Oncol Lett; 2020 Nov; 20(5):138. PubMed ID: 32934706
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer.
Telang N
Oncol Lett; 2018 Jan; 15(1):642-648. PubMed ID: 29434827
[TBL] [Abstract][Full Text] [Related]
4. Drug-Resistant Stem Cells: Novel Approach for Colon Cancer Therapy.
Telang N
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269660
[TBL] [Abstract][Full Text] [Related]
5. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
Telang N; Katdare M
Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.
Katdare M; Kopelovich L; Telang N
Ann N Y Acad Sci; 2001 Dec; 952():169-74. PubMed ID: 11795437
[TBL] [Abstract][Full Text] [Related]
7. Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer.
Hassen S; Ali N; Chowdhury P
World J Gastrointest Pathophysiol; 2012 Jun; 3(3):71-9. PubMed ID: 22737591
[TBL] [Abstract][Full Text] [Related]
8. Prevention of early-onset familial/hereditary colon cancer: new models and mechanistic biomarkers (review).
Telang NT; Li G; Katdare M
Int J Oncol; 2006 Jun; 28(6):1523-9. PubMed ID: 16685453
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Tumoral MLH1-Expression in MLH1-/PMS2-Deficient Colon Cancer Is Indicative of Sporadic Colon Cancer and Not HNPCC.
Tarancón-Diez M; Büttner R; Friedrichs N
Pathol Oncol Res; 2020 Jul; 26(3):1435-1439. PubMed ID: 30613919
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell Models for Breast and Colon Cancer: Experimental Approach for Drug Discovery.
Telang NT
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012489
[TBL] [Abstract][Full Text] [Related]
11. Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations.
Itano O; Yang K; Fan K; Kurihara N; Shinozaki H; Abe S; Jin B; Gravaghi C; Edelmann W; Augenlicht L; Kopelovich L; Kucherlapati R; Lamprecht S; Lipkin M
Carcinogenesis; 2009 Nov; 30(11):1923-6. PubMed ID: 19755659
[TBL] [Abstract][Full Text] [Related]
12. Cell culture model for colon cancer prevention and therapy: an alternative approach to animal experimentation.
Telang N; Katdare M
ALTEX; 2007; 24(1):16-21. PubMed ID: 17361317
[TBL] [Abstract][Full Text] [Related]
13. Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
Beck NE; Tomlinson IP; Homfray TF; Frayling IM; Hodgson SV; Bodmer WF
Gut; 1997 Aug; 41(2):235-8. PubMed ID: 9301504
[TBL] [Abstract][Full Text] [Related]
14. Normal colonic mucosa in hereditary non-polyposis colorectal cancer shows no generalised increase in somatic mutation.
Williams GT; Geraghty JM; Campbell F; Appleton MA; Williams ED
Br J Cancer; 1995 May; 71(5):1077-80. PubMed ID: 7734304
[TBL] [Abstract][Full Text] [Related]
15. Accelerated growth of intestinal tumours after radiation exposure in Mlh1-knockout mice: evaluation of the late effect of radiation on a mouse model of HNPCC.
Tokairin Y; Kakinuma S; Arai M; Nishimura M; Okamoto M; Ito E; Akashi M; Miki Y; Kawano T; Iwai T; Shimada Y
Int J Exp Pathol; 2006 Apr; 87(2):89-99. PubMed ID: 16623753
[TBL] [Abstract][Full Text] [Related]
16. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.
Konishi M; Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Onda A; Okumura Y; Kishi N; Iwama T; Mori T; Koike M; Ushio K; Chiba M; Nomizu S; Konishi F; Utsunomiya J; Miyaki M
Gastroenterology; 1996 Aug; 111(2):307-17. PubMed ID: 8690195
[TBL] [Abstract][Full Text] [Related]
17. Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome.
Froggatt NJ; Brassett C; Koch DJ; Evans DG; Hodgson SV; Ponder BA; Maher ER
J Med Genet; 1996 Sep; 33(9):726-30. PubMed ID: 8880570
[TBL] [Abstract][Full Text] [Related]
18. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
Couturier D
Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
[TBL] [Abstract][Full Text] [Related]
19. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer.
Telang N
Biomed Rep; 2017 Sep; 7(3):199-204. PubMed ID: 28819559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
